Britain expects to have 10 million doses of Pfizer/BioNTech’s candidate Covid-19 vaccine obtainable by the tip of the yr if regulators approve it, Prime Minister Boris Johnson‘s spokesman mentioned on Monday, following constructive medical trial outcomes.